# Short-Term Versus 6-Week Prednisone in The Treatment of Subacute Thyroiditis

> **NCT06285617** · PHASE3 · UNKNOWN · sponsor: **Xinqiao Hospital of Chongqing** · enrollment: 600 (estimated)

## Conditions studied

- Subacute Thyroiditis

## Interventions

- **DRUG:** 1-week predisone+1-week celecoxib
- **DRUG:** 6-weeks predisone

## Key facts

- **NCT ID:** NCT06285617
- **Lead sponsor:** Xinqiao Hospital of Chongqing
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-04-01
- **Primary completion:** 2025-01-31
- **Final completion:** 2025-04-30
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2024-02-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06285617

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06285617, "Short-Term Versus 6-Week Prednisone in The Treatment of Subacute Thyroiditis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06285617. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*